Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058-70.
Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem. 2004;26(1-2):37-56.
Ferré N, Camps J, Cabré M, Paul A, Joven J. Hepatic paraoxonase activity alterations and free radical production in rats with experimental cirrhosis. Metabolism. 2001;50(9):997-1000.
Rautiainen S, Lindblad BE, Morgenstern R, Wolk A. Total antioxidant capacity of the diet and risk of age-related cataract: a population-based prospective cohort of women. JAMA Ophthalmology. 2014;132(3):247-52.
Marnett LJ. Oxy radicals, lipid peroxidation and DNA damage. Toxicology. 2002;181-182:219-22.
Stein SA, Lamos EM, Davis SN. A review of the efficacy and safety of oral antidiabetic drugs. Expert Opin Drug Saf. 2013; 12(2):153-75.
Flemming N, Borg M, Nielsen J, Helle R, Philippe G. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem. 1997;43(7):1209-14.
Zargari A. Medicinal Plants. Tehran: Tehran University Publications; 1997.
El-Wahab A, Ghareeb D A, Sarhan E, Abu-Serie M, Demellawy M. In vitro biological assessment of berberis vulgaris and its active constituent, berberine: antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects. BMC Complement Altern Med. 2013;13(1):218-30.
Arayne MS, Sultana N, Bahadur SS. The Berberis story: Berberis vulgaris in therapeutics. Pak J Pharm Sci. 2007;20(1):83-92.
Dong H, Zhao Y, Zhao L, Lu F. The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials. Planta Med. 2013;79(6):437-46.
Fatehi M, Saleh TM, Fatehi-Hassanabad Z, Farrokhfal K, Jafarzadeh M, Davodi S. A pharmacological study on Berberis vulgaris fruit extract. J Ethnopharmacol. 2005;102(1):46-52.
Ivanovska N, Philipov S. Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids. Int J Immunopharmacol. 1996;18(10):553-61.
Nawel Meliani, Mohamed A, Hocine A, Boufeldja T. Hypoglycaemic effect of Berberis vulgaris L. in normal and streptozotocin-induced diabetic rats. Asian Pac J Trop Biomed. 2011;1(6):468-71.
Mokhber-Dezfuli N, Saeidnia S, Gohari AR, Kurepaz-Mahmoodabadi M. Phytochemistry and pharmacology of berberis species. Pharmacogn Rev. 2014;8(15):8-15.
Latha M, Pari L. Antidiabetic effect of Scoparia dulcis: effect on lipid peroxidation in streptozotocin diabetes. Gen Physiol Biophys. 2005;24(1):13-26.
Petrola MJ, de Castro AJ, Pitombeira MH, Barbosa MC, Quixadá AT, Duarte FB. Serum concentrations of nitrite and malondialdehyde as markers of oxidative stress in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. Rev Bras Hematol Hemoter. 2012;34(5):352-5.
Hemmati M, Asghari S, Zohoori E. Study of changes in adiponectin level in streptozotocin induced diabetic rats treated with aqueous extract of berberis vulgaris. J Birjand Univ Med Sci. 2014; 21(1):27-34. [Persian]
Elekofehinti OO, Kamdem JP, Kade IJ, Rocha JB, Adanlawo IG. Hypoglycemic, antiperoxidative and antihyperlipidemic effects of saponins from Solanum anguivi Lam. fruits in alloxan-induced diabetic rats. S Afr J Bot. 2013;88:56-61.
Hermenean A, Popescu C, Ardelean A, Stan M, Hadaruga N, Mihali CV. Hepatoprotective effects of berberis vulgaris L. extract/β cyclodextrin on carbon tetrachloride-induced acute toxicity in mice. Int J Mol Sci. 2012;13(7):9014-34.
Javadzadeh S. Therapeutic application of different parts Berberis vulgaris. Int J Agric Crop Sci. 2012;4(7):404-8.
Farhadi A, Gavadifar k. Effects of Berberise Vulgaris fruit extract on blood cholesterol and triglyceride in hyperlipidemic patients. Kumesh. 2008;9(3):211-6.